Effect of silymarin in inflammatory bowel disease
Phase 3
- Conditions
- Inflammatory Bowel Disease.Noninfective inflammatory bowel diseaseK50-K52
- Registration Number
- IRCT20101107005123N3
- Lead Sponsor
- Mashhad University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 40
Inclusion Criteria
Inflammatory bowel disease
Exclusion Criteria
The patient's unwillingness to visit the gastroenterology clinic regularly for regular examinations and check-ups
Presence of any other comorbidities
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Clinical Symptoms. Timepoint: Before the start of the study, one month and three months after the start of the intervention. Method of measurement: Questionnaire including abdominal pain, frequency of defecation, mobility and endoscopy findings.
- Secondary Outcome Measures
Name Time Method